Rebus Holdings, Inc. (RBSH)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Oct 9, 2026
Rebus Holdings Market Cap
Rebus Holdings has a market cap or net worth of $32 as of October 12, 2026. It is the 53,125th most valuable company in the world and the 9,120th biggest in the United States. Its market cap has decreased by 99.00% in one year.
Market Cap
32.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#9,120 United States
PE Ratio
0.00
ChartMarket Cap Chart
Since November 2, 2009, Rebus Holdings's market cap has decreased from 30.37M to 32.00, a decrease of -100.00%. That is a compound annual growth rate of -55.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 32.00 | - |
| Dec 31, 2024 | 32.00 | -99.98% |
| Dec 29, 2023 | 162.27K | -32.67% |
| Dec 30, 2022 | 241.00K | -12.12% |
| Dec 31, 2021 | 274.23K | -69.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Iterum Therapeutics | 53.00 |
| Baudax Bio | 52.00 |
| Core One Labs | 47.00 |
| Mymetics | 46.00 |
| Claritas Pharmaceuticals | 38.00 |
| Intellipharmaceutics International | 33.00 |
| HAVN Life Sciences | 29.00 |
| Neurobiological Technologies | 27.00 |